| - GRCh37:
- Chr22:17589433
- GRCh38:
- Chr22:17108543
| IL17RA | K408E, K442E | Immunodeficiency 51 | Uncertain significance (Feb 11, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17589867
- GRCh38:
- Chr22:17108977
| IL17RA | | Immunodeficiency 51 | Likely benign (May 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17565982-20052185
| TSSK2, TUBA8, USP18, TXNRD2, UFD1, ADA2, ARVCF, ATP6V1E1, BCL2L13, BID, C22orf39, CDC45, CECR2, CECR3, CLDN5, CLTCL1, COMT, DGCR2, DGCR6, ESS2, GNB1L, GP1BB, GSC2, HDHD5, HIRA, IL17RA, MICAL3, MRPL40, PEX26, PRODH, RTL10, SEPTIN5, SLC25A1, SLC25A18, TANGO2, TBX1, TMEM121B | | Immunodeficiency 51, Vasculitis due to ADA2 deficiency | Pathogenic (Apr 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17589519
- GRCh38:
- Chr22:17108629
| IL17RA | | Immunodeficiency 51 | Likely benign (Jun 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17566056
- GRCh38:
- Chr22:17085166
| IL17RA | | Immunodeficiency 51 | Likely benign (Feb 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17582947
- GRCh38:
- Chr22:17102057
| IL17RA | | Immunodeficiency 51 | Likely benign (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17586730
- GRCh38:
- Chr22:17105840
| IL17RA | | Immunodeficiency 51 | Likely benign (Jul 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17589908
- GRCh38:
- Chr22:17109018
| IL17RA | S600C, S566C | Immunodeficiency 51 | Uncertain significance (May 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17589816
- GRCh38:
- Chr22:17108926
| IL17RA | | Immunodeficiency 51 | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17586501
- GRCh38:
- Chr22:17105611
| IL17RA | | Immunodeficiency 51 | Likely benign (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17588618
- GRCh38:
- Chr22:17107728
| IL17RA, LOC126863094 | | Immunodeficiency 51 | Likely benign (May 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17578668
- GRCh38:
- Chr22:17097778
| IL17RA | | Immunodeficiency 51 | Likely benign (Jun 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17584386
- GRCh38:
- Chr22:17103496
| IL17RA | | Immunodeficiency 51 | Benign (Sep 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17582871
- GRCh38:
- Chr22:17101981
| IL17RA | | Immunodeficiency 51 | Likely benign (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590120
- GRCh38:
- Chr22:17109230
| IL17RA | A637T, A671T | Immunodeficiency 51 | Uncertain significance (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590092
- GRCh38:
- Chr22:17109202
| IL17RA | | Immunodeficiency 51 | Likely benign (Apr 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17589881
- GRCh38:
- Chr22:17108991
| IL17RA | Y557S, Y591S | Immunodeficiency 51 | Uncertain significance (May 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17589806
- GRCh38:
- Chr22:17108916
| IL17RA | Q566R, Q532R | Immunodeficiency 51 | Uncertain significance (May 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17586804
- GRCh38:
- Chr22:17105914
| IL17RA | | Immunodeficiency 51 | Likely benign (Apr 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17565990
- GRCh38:
- Chr22:17085100
| IL17RA | | Immunodeficiency 51 | Likely benign (Mar 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590405
- GRCh38:
- Chr22:17109515
| IL17RA | G732R, G766R | Immunodeficiency 51 | Uncertain significance (Jul 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17589455
- GRCh38:
- Chr22:17108565
| IL17RA | R415H, R449H | Inborn genetic diseases, Immunodeficiency 51 | Uncertain significance (Aug 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:17578820
- GRCh38:
- Chr22:17097930
| IL17RA | | Immunodeficiency 51 | Likely benign (Apr 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17589848
- GRCh38:
- Chr22:17108958
| IL17RA | R580H, R546H | Immunodeficiency 51 | Uncertain significance (Jun 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17586738
- GRCh38:
- Chr22:17105848
| IL17RA | | Immunodeficiency 51 | Uncertain significance (Dec 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17578799
- GRCh38:
- Chr22:17097909
| IL17RA | | Immunodeficiency 51 | Likely benign (Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590489
- GRCh38:
- Chr22:17109599
| IL17RA | Q794E, Q760E | Immunodeficiency 51 | Uncertain significance (Apr 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590261
- GRCh38:
- Chr22:17109371
| IL17RA | F684V, F718V | Inborn genetic diseases, Immunodeficiency 51 | Uncertain significance (Sep 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:17565998
- GRCh38:
- Chr22:17085108
| IL17RA | S6N | Immunodeficiency 51 | Uncertain significance (Jun 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17589961
- GRCh38:
- Chr22:17109071
| IL17RA | V584L, V618L | Immunodeficiency 51 | Uncertain significance (Aug 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17589713
- GRCh38:
- Chr22:17108823
| IL17RA | R501H, R535H | Immunodeficiency 51 | Uncertain significance (Mar 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590558
- GRCh38:
- Chr22:17109668
| IL17RA | E783K, E817K | Immunodeficiency 51 | Uncertain significance (Feb 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17579724
- GRCh38:
- Chr22:17098834
| IL17RA | R124C | Immunodeficiency 51 | Uncertain significance (May 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590264
- GRCh38:
- Chr22:17109374
| IL17RA | L685F, L719F | Immunodeficiency 51 | Uncertain significance (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17583012
- GRCh38:
- Chr22:17102122
| IL17RA | | Immunodeficiency 51 | Likely benign (Jun 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17566053
- GRCh38:
- Chr22:17085163
| IL17RA | | Immunodeficiency 51 | Likely benign (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590600
- GRCh38:
- Chr22:17109710
| IL17RA | E797K, E831K | Immunodeficiency 51 | Uncertain significance (Jun 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590697
- GRCh38:
- Chr22:17109807
| IL17RA | G829A, G863A | Immunodeficiency 51 | Uncertain significance (Mar 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17584446
- GRCh38:
- Chr22:17103556
| IL17RA | | Immunodeficiency 51 | Likely benign (Apr 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590048
- GRCh38:
- Chr22:17109158
| IL17RA | V613M, V647M | Immunodeficiency 51 | Uncertain significance (Apr 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17578853
- GRCh38:
- Chr22:17097963
| IL17RA | | Immunodeficiency 51 | Likely benign (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17589576
- GRCh38:
- Chr22:17108686
| IL17RA | D489E, D455E | Immunodeficiency 51 | Uncertain significance (Jul 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17589664
- GRCh38:
- Chr22:17108774
| IL17RA | A519P, A485P | Immunodeficiency 51 | Uncertain significance (Mar 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590427
- GRCh38:
- Chr22:17109537
| IL17RA | M773R, M739R | Immunodeficiency 51 | Uncertain significance (Dec 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17589492
- GRCh38:
- Chr22:17108602
| IL17RA | | Immunodeficiency 51 | Likely benign (May 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590382
- GRCh38:
- Chr22:17109492
| IL17RA | Q724R, Q758R | Immunodeficiency 51 | Uncertain significance (Mar 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590361
- GRCh38:
- Chr22:17109471
| IL17RA | L717W, L751W | Immunodeficiency 51 | Uncertain significance (Mar 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590218
- GRCh38:
- Chr22:17109328
| IL17RA | | Immunodeficiency 51 | Likely benign (Feb 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590385
- GRCh38:
- Chr22:17109495
| IL17RA | S725N, S759N | Immunodeficiency 51 | Uncertain significance (Feb 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17581283
- GRCh38:
- Chr22:17100393
| IL17RA | | Immunodeficiency 51 | Likely benign (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17589924-17589925
- GRCh38:
- Chr22:17109034-17109035
| IL17RA | E607*, E573* | Immunodeficiency 51 | Uncertain significance (Jan 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17583073
- GRCh38:
- Chr22:17102183
| IL17RA | H215Y | Immunodeficiency 51 | Uncertain significance (Jan 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17583110-17583111
- GRCh38:
- Chr22:17102220-17102221
| IL17RA | T228fs | Immunodeficiency 51 | Pathogenic (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17585679
- GRCh38:
- Chr22:17104789
| IL17RA | P304S | Immunodeficiency 51 | Uncertain significance (Jan 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590207
- GRCh38:
- Chr22:17109317
| IL17RA | G666S, G700S | Immunodeficiency 51 | Uncertain significance (Jan 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17589983
- GRCh38:
- Chr22:17109093
| IL17RA | R591H, R625H | Immunodeficiency 51 | Uncertain significance (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17577939
- GRCh38:
- Chr22:17097049
| IL17RA | | Immunodeficiency 51 | Likely benign (Sep 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17589689
- GRCh38:
- Chr22:17108799
| IL17RA | D493G, D527G | Immunodeficiency 51 | Uncertain significance (Mar 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590257
- GRCh38:
- Chr22:17109367
| IL17RA | | Immunodeficiency 51 | Likely benign (Jan 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590354
- GRCh38:
- Chr22:17109464
| IL17RA | E715Q, E749Q | Immunodeficiency 51 | Uncertain significance (Aug 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17586789
- GRCh38:
- Chr22:17105899
| IL17RA | | Immunodeficiency 51 | Likely benign (Jun 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590423
- GRCh38:
- Chr22:17109533
| IL17RA | A738T, A772T | Immunodeficiency 51 | Uncertain significance (Jan 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17566022
- GRCh38:
- Chr22:17085132
| IL17RA | P14R | Immunodeficiency 51 | Uncertain significance (Jun 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17579715
- GRCh38:
- Chr22:17098825
| IL17RA | T121A | Immunodeficiency 51 | Uncertain significance (Dec 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17586724
- GRCh38:
- Chr22:17105834
| IL17RA | | Immunodeficiency 51 | Likely benign (Sep 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590000
- GRCh38:
- Chr22:17109110
| IL17RA | A597T, A631T | Immunodeficiency 51 | Uncertain significance (Dec 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17585644
- GRCh38:
- Chr22:17104754
| IL17RA | N292S | Immunodeficiency 51 | Uncertain significance (Jun 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590067
- GRCh38:
- Chr22:17109177
| IL17RA | H619R, H653R | Immunodeficiency 51 | Uncertain significance (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17589784
- GRCh38:
- Chr22:17108894
| IL17RA | | Immunodeficiency 51 | Likely benign (Aug 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590580
- GRCh38:
- Chr22:17109690
| IL17RA | P790Q, P824Q | Immunodeficiency 51 | Uncertain significance (Aug 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17578779
- GRCh38:
- Chr22:17097889
| IL17RA | Q86K | Immunodeficiency 51 | Uncertain significance (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590064
- GRCh38:
- Chr22:17109174
| IL17RA | P618R, P652R | Immunodeficiency 51 | Uncertain significance (Apr 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:17566064
- GRCh38:
- Chr22:17085174
| IL17RA | P28L | Immunodeficiency 51 | Uncertain significance (Jan 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590590
- GRCh38:
- Chr22:17109700
| IL17RA | | Immunodeficiency 51 | Likely benign (Jul 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590187
- GRCh38:
- Chr22:17109297
| IL17RA | R693P, R659P | Immunodeficiency 51 | Uncertain significance (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17589879
- GRCh38:
- Chr22:17108989
| IL17RA | | Immunodeficiency 51 | Likely benign (Sep 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17589795
- GRCh38:
- Chr22:17108905
| IL17RA | | Immunodeficiency 51 | Likely benign (Jul 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17579708
- GRCh38:
- Chr22:17098818
| IL17RA | Q118H | Immunodeficiency 51 | Uncertain significance (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590313
- GRCh38:
- Chr22:17109423
| IL17RA | A701V, A735V | Immunodeficiency 51 | Uncertain significance (Jul 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17583042
- GRCh38:
- Chr22:17102152
| IL17RA | | Immunodeficiency 51 | Likely benign (Jul 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17585630
- GRCh38:
- Chr22:17104740
| IL17RA | | Immunodeficiency 51 | Likely benign (Jun 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17583014
- GRCh38:
- Chr22:17102124
| IL17RA | | Immunodeficiency 51 | Likely benign (Jun 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17589666-17589667
- GRCh38:
- Chr22:17108776-17108777
| IL17RA | Y489fs, Y523fs | Immunodeficiency 51 | Uncertain significance (Jun 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17579686
- GRCh38:
- Chr22:17098796
| IL17RA | G111V | Immunodeficiency 51 | Uncertain significance (Jun 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17578728
- GRCh38:
- Chr22:17097838
| IL17RA | T69fs | Immunodeficiency 51 | Pathogenic (May 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17577934
- GRCh38:
- Chr22:17097044
| IL17RA | | Immunodeficiency 51 | Likely benign (Oct 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590620
- GRCh38:
- Chr22:17109730
| IL17RA | | Immunodeficiency 51 | Likely benign (Jun 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590123
- GRCh38:
- Chr22:17109233
| IL17RA | A638T, A672T | Immunodeficiency 51 | Uncertain significance (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590162
- GRCh38:
- Chr22:17109272
| IL17RA | P651T, P685T | Immunodeficiency 51, Inborn genetic diseases | Uncertain significance (Jun 12, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:17582880
- GRCh38:
- Chr22:17101990
| IL17RA | | Immunodeficiency 51 | Likely benign (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17589877
- GRCh38:
- Chr22:17108987
| IL17RA | L590F, L556F | Immunodeficiency 51 | Uncertain significance (Mar 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590525
- GRCh38:
- Chr22:17109635
| IL17RA | E772K, E806K | Immunodeficiency 51 | Uncertain significance (Feb 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17586819
- GRCh38:
- Chr22:17105929
| IL17RA | | Immunodeficiency 51 | Likely benign (May 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590291
- GRCh38:
- Chr22:17109401
| IL17RA | L694F, L728F | Immunodeficiency 51 | Uncertain significance (Oct 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17585660
- GRCh38:
- Chr22:17104770
| IL17RA | | Immunodeficiency 51 | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590416
- GRCh38:
- Chr22:17109526
| IL17RA | | Immunodeficiency 51 | Likely benign (Apr 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17585717
- GRCh38:
- Chr22:17104827
| IL17RA | | Immunodeficiency 51 | Likely benign (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17589643
- GRCh38:
- Chr22:17108753
| IL17RA | D512N, D478N | Inborn genetic diseases, Immunodeficiency 51 | Uncertain significance (Aug 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:17585665
- GRCh38:
- Chr22:17104775
| IL17RA | A299E | Immunodeficiency 51 | Uncertain significance (May 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:17590033
- GRCh38:
- Chr22:17109143
| IL17RA | E608K, E642K | Immunodeficiency 51 | Uncertain significance (Jun 26, 2022) | criteria provided, single submitter |